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Mitochondria contain multiple copies of mitochondrial DNA (mtDNA) that encode ribosomal 
and transfer RNAs and many essential proteins required for oxidative phosphorylation. 
Mitochondria are essential for generation of ATP, but also generate reactive oxygen species 
(ROS) as a by-product of the electron transport chain. Oxidative damage to mitochondrial 
DNA induces respiratory chain dysfunction, resulting in reduced ATP synthesis and further 
increased ROS generation. The reduced mitochondrial respiration may be accompanied by 
increased glycolysis and increased lactate production, and these changes can be detected 
by reduced oxygen consumption and increased extracellular pH of tissues or cultured cells.  
Mitochondrial dysfunction leading to reduced mitochondrial respiration has been implicated 
in both normal vascular ageing and a variety of cardiovascular diseases,, including 
atherosclerosis, heart failure, and aneurysm formation. For example, reduced mitochondrial 
DNA (mtDNA) copy number, mitochondrial respiration and expression of specific electron 
transport chain complexes has been shown in vascular smooth muscle cells (VSMCs) 
derived from human atherosclerotic plaques1-3. Mitochondriogenesis and mitophagy are also 
important regulators of mitochondrial health and number. ROS induce VSMC mitophagy, 
and similarly plaque VSMCs show increased mitophagy compared with normal arterial 
VSMCs2.  
 
Mitochondrial dysfunction has been associated with arterial aneurysm formation, but most 
studies have analysed abdominal aortic aneurysms (AAA) rather than genetic thoracic 
aneurysmal aorta syndromes. For example, AAA show differential expression of a number of 
genes associated with mitochondrial function and oxidative phosphorylation4 and 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) gene 
expression is decreased in human AAA and angiotensin (Ang) II-induced AAA in mice. 
Similarly, the intima/media layer of AAA vessels showed reduced expression of a number of 
markers of mitochondrial biogenesis, including PGC1, ATP synthase and citrate synthase5. 
Mitochondrial dysfunction is also associated with arterial ageing and medial degeneration in 
humans and mice, associated with changes in arterial expression of genes that regulate 
mitochondrial number, while correction of mitochondrial dysfunction can delay arterial 
ageing6. However, mitochondrial dysfunction has not been associated with thoracic 
aneurysmal aorta syndromes, and its role in causing rather than a consequence of 
aneurysm formation is unclear.  
 
Fibulin-4 is a secreted glycoprotein which tethers elastic fibres VSMCs, and  patients with 
mutations in Fibulin-4 develop  aortic aneurysms, arterial tortuosity and elastin 
abnormalities. Fibulin-4R/R mice (which have 4-fold reduced Fibulin 4 levels) develop 
progressive ascending aneurysm formation and early death around 3m of age, with 
Transforming growth factor β (TGFβ) signalling a critical regulator of aneurysm formation7. In 
the current edition of CVR, van der Pluijm et al8 used proteomics, genomics and functional 
experiments to study thoracic aortas of aneurysmal Fibulin-4R/R animals. Fibulin-4R/R mice 
showed alterations in protein composition affecting predominantly extracellular matrix (ECM) 
and cytoskeleton proteins, but also mitochondrial proteins and upregulation of TGF1. 
VSMCs from Fibulin-4R/R mice had smaller mitochondria, but similar numbers of mitochondria 
and increased expression of mitochondrial complexes I-IV. VSMCs derived from these mice also 
showed lower uncoupled oxygen consumption rates, consistent with reduced mitochondrial 
respiration, but increased acidification rates, perhaps reflecting increased glycolysis. Aortas 
from aneurysmal Fibulin-4R/R mice also displayed increased ROS levels. Interestingly lower 
oxygen consumption was also found in Tgfbr-1M318R/+ mouse VSMCs, a mouse model for 
Loeys-Dietz syndrome, and human fibroblasts from Marfan (FBN1) and Loeys-Dietz 
syndrome (TGFBR2 and SMAD3) patients. Fibulin-4R/R mouse aortas had significantly 
decreased mRNA expression of Peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC1) and PGC1β compared to Fibulin-4+/+ aortas, and activity of 
PGC1α, a key regulator of both mitochondrial function and organismal metabolism, was 
markedly reduced. Interestingly, TGFβ also reduced PGC1α transcription, while activation of 
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PGC1α increased both basal and maximum oxygen consumption in Fibulin-4R/R VSMCs 
and improved cell proliferation.  
 
The authors outline a possible pathway linking Fibulin 4 reduction with mitochondrial 
dysfunction that include ROS, TGF, and PGC1(Figure 1). Thus, Fibulin deficiency 
leading to disorganised ECM proteins can result in increased TGF1 signalling. ROS may 
induce mtDNA damage and mitochondrial dysfunction, characterised by reduced 
mitochondrial respiration, a switch of energy substrate for ATP generation, and further 
increases in ROS. Mitochondrial biogenesis involves an intricate, complicated network of 
transcription factors that activate target genes encoding enzymes of fatty acid oxidation, 
oxidative phosphorylation, and anti-oxidant defences. PGC-1α regulates expression of this 
network, and directly links external physiological stimuli to the regulation of mitochondrial 
biogenesis and function. Mitochondrial dysfunction would normally result in compensatory 
mitogenesis, but increased TGF1 signalling due to concomitant abnormalities in either 
ECM proteins or cytoskeletal filaments result in reduced expression and transcriptional 
activity of PGC1, and reduced expression and activation of its targets including PPAR, 
PPARand PPAR. PPAR and . have major roles regulating expression of proteins 
involved in extra and intramitochondrial fatty acid transport and oxidation, while PPAR 
regulates antioxidant synthesis, such that reduced expression/activity may increase ROS 
further. 
 
As always, the current paper raises a number of important questions. First, how does a 
deficiency in a protein involved in ECM structural integrity lead to altered mitochondrial 
function and metabolism. Although this might be through structural abnormalities in 
mitochondria, TGFβ signalling (which has been implicated in a number of human aneurysm 
syndromes) negatively regulates PGC1α levels9,10 and may be the major pathway involved. 
However, arterial ageing, itself associated with ROS and VSMC loss and cell senescence, is 
accompanied by reductions in mtDNA copy number, mitochondrial respiration, and 
expression of PGC1 and a number of other genes regulating mtDNA synthesis6. The 
changes noted in Fibulin-4R/R mice may therefore also be due to loss and/or senescence of 
VSMCs in the arterial wall, with reduced mitochondrial function and increased ROS. MtDNA 
synthesis is directly regulated by a number of proteins, including the mitochondrial 
transcription factor A (TFAM), mitochondrial helicase Twinkle, and PGC1 It would 
therefore be important to examine mtDNA copy number and mtDNA damage in both mouse 
models of thoracic aortic aneurysm syndromes and human patients, and markers of mtDNA 
synthesis and mitochondrial turnover including fission/fusion and mitophagy. In addition, we 
currently lack effective treatments to prevent arterial expansion and rupture in thoracic aortic 
aneurysm syndromes, and the current paper raises the possibility that therapy aimed at 
increasing PGC1 or potent PPAR and  agonists might be of benefit. If Fibulin-4R/R mice 
recapitulate the structural abnormalities, mitochondrial dysfunction and cell signalling defects 
seen in human patients, then preclinical studies using these agents would be important.  
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Figure 1 
Model implicating mitochondrial dysfunction in aortic aneurysm formation 
A full description is provided in the text 
 
ECM; extracellular matrix. VSMC; vascular smooth muscle cell. TGFb; transforming growth 
factor beta. PGC1a; peroxisome proliferator activated receptor gamma coactivator 1 alpha. 
OCR; oxygen consumption rate. ECAR; extracellular acidification rate. Tw; Twinkle helicase. 
ROS; reactive oxygen species. ATP; adenosine triphosphate.   
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